BMC Medical Co. Ltd. A (301367) — Capital Reinvestment Ratio
BMC Medical Co. Ltd. A (301367) has a Capital Reinvestment Ratio of 0.25x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥130.16 Million) in capital expenditures (CN¥32.22 Million). Check 301367 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BMC Medical Co. Ltd. A Capital Reinvestment Ratio (2020–2025)
This chart tracks BMC Medical Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of BMC Medical Co. Ltd. A.
Annual Capital Reinvestment Ratio for BMC Medical Co. Ltd. A (2020–2025)
Year-by-year Capital Reinvestment Ratio for BMC Medical Co. Ltd. A from 2020 to 2025. See 301367 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥130.16 Million | CN¥32.22 Million | ▲ +139.5% |
| 2024 | 0.10x | CN¥154.08 Million | CN¥15.93 Million | ▼ -35.3% |
| 2023 | 0.16x | CN¥151.11 Million | CN¥24.12 Million | ▲ +152.3% |
| 2022 | 0.06x | CN¥375.21 Million | CN¥23.75 Million | ▼ -34.1% |
| 2021 | 0.10x | CN¥104.40 Million | CN¥10.03 Million | ▲ +66.5% |
| 2020 | 0.06x | CN¥267.41 Million | CN¥15.43 Million | — |